Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market

This post was originally published on this site

Shares of Vertex Pharmaceuticals Inc. VRTX, -0.60% dropped 0.60% to $178.94 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX, -0.19% falling 0.19% to 4,391.34 and Dow Jones Industrial Average DJIA, -0.03% falling 0.03% to 34,746.25. This was the stock’s second consecutive day of losses. Vertex Pharmaceuticals Inc. closed $102.05 short of its 52-week high ($280.99), which the company reached on October 13th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson JNJ, -0.25% fell 0.25% to $160.93, Merck & Co. Inc. MRK, -1.60% fell 1.60% to $80.63, and AbbVie Inc. ABBV, +0.28% rose 0.28% to $111.18. Trading volume (1.2 M) remained 502,714 below its 50-day average volume of 1.7 M.

Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.